$ERAS leads the live board in Mixed Basket with a Factor Residual Spike

🇺🇸 $ERAS (Erasca, Inc.) is showing signs of a weakening unusual relative-strength move within the Mixed Basket, signaling a potential shift in biotech momentum. Despite inflows into Erasca, the active setup suggests the move is losing steam, with follow-through still thin. This nuance indicates the market may be testing the sustainability of this biotech rally amid broader mixed signals. The proof lies in the fact that most movers are clustered in Healthcare, specifically Biotechnology, where Erasca operates as a clinical-stage oncology player focused on RAS/MAPK pathway-driven cancers. While FTDR leads the flow, the developing pattern around ERAS hints at a fragile setup rather than a confirmed breakout. The key next step is watching for a second wave of linked names to confirm whether this mixed move broadens or remains a one-stock phenomenon.